NFL Collective Bargaining Agreement

Article 39
Players’ Rights To Medical Care and Treatment

Section 20(a)(ii)(B)
Prescription Medication and Pain Management Program

(a)(ii)(B)

The Pain Management Guidelines will reflect the FDA mandate that (i) players are given the FDA drug warning and interaction sheet for each prescription at the time the prescription is given to the Player (as generated by the pharmacy dispensing the medication), (ii) players understand the potential adverse consequences and side effects for any medications prescribed, and (iii) the club medical staff document whatever further communications occurs with regard to the prescription. The Pain Management Guidelines shall also provide best practices for club medical staff to follow-up with the player-patient at specified intervals.